EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark KINENZASE was filed as Word mark on 08/21/2006 at the European Union Intellectual Property Office.
It was registered as a trademark on 08/16/2007.
The current status of the mark is "Registration expired".
| Trademark form | Word mark |
| File reference | 005312509 |
| Application date | August 21, 2006 |
| Publication date | February 5, 2007 |
| Entry date | August 16, 2007 |
| Expiration date | August 21, 2016 |
Trademark owner
Lilly Corporate Center
46285 Indianapolis,
US
46285 Indianapolis,
US
Trademark representatives
Bedford House, John Street
WC1N 2BF London
GB
goods and services
5
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, musculoskeletal diseases and disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, and urological disorders; pharmaceutical preparations
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| June 28, 2017 | Extension, Trade mark expired | ||
| March 18, 2011 | Change Representative, Published | ||
| August 27, 2007 | Change Representative, Published |
ID: 11005312509